Outsourced Drug Discovery Market Size Is Anticipated To Reach US$ 56.7 Billion at a CAGR of 12.1% By 2028 | Share Analysis, Future Insights, Growth Estimation and Industry Trends

Overview:

Outsourced drug discovery is a contract-based procedure carried out by contract research organizations (CRO) and contract manufacturing organizations (CMO) (CMO). Contract research organizations provide drug discovery and development assistance to the pharmaceutical, biotechnology, and medical device sectors. CROs support drug discovery and development services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2847

Drivers:

Partnership tactics used by major players in the drug research and development process are projected to boost the global outsourced drug discovery market worldwide. For instance, in April 2019, Medicine Discovery Catapult partnered with 22 U.K.-based contract research groups and launched a virtual R&D discovery services platform comprised of more than 20 CROs, which would assist small- to medium-sized companies in delivering drug discovery projects.

Furthermore, increasing new site launches for clinical research practice development are predicted to drive the global outsourced drug discovery market growth. For instance, INC Research Holdings, Inc., a contract research firm, formed the industry’s first Site Advocacy Group (SAG) in June 2015 to support the development and advancement of clinical research operations. SAG’s research and development operations are focused on schizophrenia, depression, and bipolar illness.

Key Development:

The market’s key players are concentrating on the launch of drug development services. For instance, in March 2018, Evotec AG announced INDiGO, a new drug discovery service. This service is employed during the drug research and development stages. INDiGO is an integrated drug development technology that helps to speed drug development procedures from candidate selection through NDA filing. It has the potential to shorten and lower the cost of the drug development process. Furthermore, new drug discovery platform introductions are likely to drive the growth of the worldwide outsourced drug discovery market.

Key Players:

Major players active in the global outsourced drug discovery market are Bioduro LLC, Charles River Laboratories (CRL), Shanghai Medicilon, TCG Lifesciences, Chempartner, Syngene International Ltd. Jubilant Biosys Ltd, Evotec AG, Sundia Meditech Co. Ltd, Pharmaron Inc., and Aurigene Accelerating Discovery.

Buy This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2847

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Outsourced Drug Discovery Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Outsourced Drug Discovery Industry Impact

Chapter 2 Global Outsourced Drug Discovery Competition by Types, Applications, and Top Regions and Countries
2.1 Global Outsourced Drug Discovery (Volume and Value) by Type
2.3 Global Outsourced Drug Discovery (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Outsourced Drug Discovery Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Outsourced Drug Discovery Market Analysis
Chapter 6 East Asia Outsourced Drug Discovery Market Analysis
Chapter 7 Europe Outsourced Drug Discovery Market Analysis
Chapter 8 South Asia Outsourced Drug Discovery Market Analysis
Chapter 9 Southeast Asia Outsourced Drug Discovery Market Analysis
Chapter 10 Middle East Outsourced Drug Discovery Market Analysis
Chapter 11 Africa Outsourced Drug Discovery Market Analysis
Chapter 12 Oceania Outsourced Drug Discovery Market Analysis
Chapter 13 South America Outsourced Drug Discovery Market Analysis
Chapter 14 Company Profiles and Key Figures in Outsourced Drug Discovery Business
Chapter 15 Global Outsourced Drug Discovery Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology